CatSci Acquires Reach Separations
June 25, 2024
CatSci Ltd, backed by Keensight Capital, has acquired Reach Separations, a specialist chromatography provider headquartered in the United Kingdom. The deal expands CatSci's CMC and separation science capabilities, enabling end-to-end analytical and purification services from discovery through to manufacture for biotech, pharma and related customers.
- Buyers
- CatSci Ltd, Keensight Capital
- Targets
- Reach Separations
- Platforms
- CatSci Ltd
- Industry
- Healthcare Services
- Location
- Nottinghamshire, United Kingdom
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Keensight Capital Invests in CatSci Ltd
January 15, 2022
Healthcare Services
Keensight Capital has made a growth investment in CatSci Ltd, a Cardiff‑headquartered Contract Research Organisation (CRO) formed as a 2010 spin‑out from AstraZeneca. Keensight will invest alongside CatSci founders, senior management and employees to support the company's continued growth and capability expansion in small‑molecule and oligonucleotide CMC development and scale‑up.
-
Discovery Life Sciences Acquires ReachBio Research Labs
April 11, 2023
Biotechnology
Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.
-
Astrea Bioseparations Acquires Delta Precision Ltd
January 9, 2023
Biotechnology
Astrea Bioseparations has acquired Delta Precision Ltd, a manufacturer of high-performance chromatography columns for the biotechnology and pharmaceutical industries. The acquisition expands Astrea Bio's product offering to include a full range of chromatography columns and accelerates its ability to develop and bring new purification technologies to biomanufacturing customers.
-
Calibre Scientific Acquires Greyhound Chromatography
August 14, 2024
Healthcare Services
Calibre Scientific has acquired Greyhound Chromatography and Allied Chemicals Ltd., a UK provider of chromatography consumables and analytical reference standards. The acquisition expands Calibre Scientific’s distribution operations in the UK & Ireland and strengthens its analytical standards and chromatography product portfolio to better serve pharmaceutical, environmental, food, forensic and petrochemical laboratories worldwide.
-
Sartorius Acquires WaterSep BioSeparations
December 9, 2020
Medical Devices
German life‑science group Sartorius, via its subgroup Sartorius Stedim Biotech, has acquired U.S.-based purification specialist WaterSep BioSeparations LLC. The deal, valued at approximately $27 million plus an earn‑out of up to $9 million, adds hollow‑fiber crossflow filtration and single‑use bioprocessing devices aimed at gene and cell therapy, vaccine production and intensified bioprocessing to Sartorius' separation portfolio.
-
Calibre Scientific Acquires American Chromatography Supplies (ACS)
June 17, 2024
Healthcare Services
Calibre Scientific has acquired American Chromatography Supplies LLC (ACS), a U.S. supplier of chromatography consumables, expanding Calibre's chromatography product portfolio and distribution capabilities. ACS, founded in 2011, supplies vials, caps, HPLC/GC columns and other lab consumables to pharmaceutical, academic, clinical, food & beverage, and environmental laboratories in the United States.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.